Corporate VP PAREXEL Consulting, PAREXEL
Alberto Grignolo has 36+ years of experience as a regulatory and drug development professional including consulting for pharmaceutical and biotechnology companies. He is a driver of a successful worldwide consulting business and established PAREXEL’s Japan Consulting Services. He...
Read More →
Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company
Mark Kryah has been leading projects from early to late phase development for over 20 years. He has extensive international and cross-cultural experience in CMC, clinical and global development, with multiple alliance collaborations and co-development partnerships. He has led numerous...
Read More →
Senior Scientific Liaison, DIA
Dr. Raleigh Malik is a Sr. Scientist at DIA in Washington, DC, where she supports the advancement of DIA’s global content strategy by providing scientific expertise related to therapeutic drug development and regulatory disciplines. Prior to joining DIA, Dr. Malik supported medical...
Read More →
Global Associate Director, Content Collaboration, DIA
Dr. Ranjini Prithviraj is Senior Managing Editor and Associate Director of Publications at DIA, where she provides strategic thought leadership and delivers content that advances DIA’s mission through various media, including traditional journal publications. Prior to DIA, she was...
Read More →
Vice President, Data Analytics and Epidemiology, RW Strategy and Analytics, Mapi
Dr. Margaret ‘Meg’ Richards has over 25 years' experience as an epidemiologist in the public health, biopharmaceutical, and contract research sectors. Prior to joining PPD as Executive Director of Epidemiology, Dr. Richards served as a Director of Global Patient Safety & Risk...
Read More →
